The B. Braun healthcare facility in Collooney, Co Sligo is to close with the loss of approximately 80 jobs.

The plant, which manufactures wound care products for international markets, will be closed in a phased manner over the next year and a half.

The company's research and development facility in Sligo will, however, remain open.

It is understood the company currently employs 89 people. It said that "the proposed closure is necessary because the volume of production available to the site is too low to make the plant viable any longer.

"Having exhausted a number of alternative approaches there is no feasible means of increasing production volumes to operate at even a break-even level let alone a level that utilises its full capacity."

The company expressed regret at the impact of the decision on "our colleagues in Collooney, many of whom have worked with us for a long time.

"We have a great team on site and our immediate priority is to support all affected colleagues through this difficult period. The site is staffed by highly skilled professionals, dedicated to delivering the highest quality wound care products for international markets."

A statement from B. Braun said the company will do its best to support its colleagues and minimise the impact where it can.

The company said that wound care is a strategically important product category for B. Braun Group and it will retain a specialist global research and development unit focused on wound care in Sligo.

It confirmed that no other B. Braun operations in Ireland are included in this proposal and all facilities continue to operate and supply vital healthcare products and services as normal.